What Happens If You Hit a Blood Vessel While Injecting?

Hitting a blood vessel during an injection usually causes nothing worse than a bruise, but in uncommon cases it can trigger complications ranging from localized tissue damage to life-threatening systemic reactions. The outcome depends on several factors: whether the needle enters a vein or an artery, what substance is being injected, how much of it reaches the bloodstream, and where on the body the injection takes place. Most accidental vessel punctures are minor events that resolve on their own, yet understanding the full range of possibilities helps explain why healthcare providers take specific precautions and why certain injection scenarios carry real risk.

The Most Common Outcome Is a Bruise

When a needle nicks or passes through a small blood vessel during an intramuscular or subcutaneous injection, blood leaks into the surrounding tissue. The result is a hematoma, the medical term for what most people recognize as a bruise. It may sting, swell, and turn purple or yellowish over the next few days, but it generally heals without treatment. A large retrospective study of hospitalized patients who received intramuscular injections found that verified injection-site bleeding complications were extremely rare, occurring in roughly two out of every ten thousand injections even among patients on blood-thinning medications.¹ For the vast majority of people getting a routine shot, a small bruise is the beginning and end of the story.

That said, a bruise from an injection can occasionally grow large enough to cause problems. If enough blood pools inside a closed muscle compartment, the pressure can compress nearby nerves and smaller vessels. This is called compartment syndrome, and while it is rare from a standard injection, it is a recognized complication when a larger vessel is punctured or when a patient’s blood does not clot normally.

Why It Matters Whether You Hit a Vein or an Artery

Veins and arteries behave very differently when punctured. Veins carry blood at relatively low pressure, so a needle poke usually produces modest bleeding that stops quickly once the needle is withdrawn. Arteries are under much higher pressure, which means they bleed faster and the blood can leak further into surrounding tissue. More critically, injecting a substance directly into an artery sends it at high concentration to the tissues downstream, rather than diluting it through the larger venous system and the heart first.

Accidental intra-arterial injection is the scenario clinicians worry about most. When certain drugs enter an artery, they can cause intense pain, numbness, loss of motor function, tissue death, and in severe cases, loss of a limb.² The proposed mechanism involves the drug triggering spasm or damage in the artery wall, which restricts blood flow to the tissue beyond the injection point.³ Not every drug causes this kind of damage. A pediatric case series found that many commonly used anesthetics, when accidentally injected into arteries, did not cause serious harm, with the notable exceptions of strongly alkaline or highly fat-soluble drugs like thiopental and diazepam, which are consistently linked to tissue necrosis.²

Warning signs of an accidental arterial injection include unusually bright red blood in the syringe, severe burning pain that shoots toward the hand or foot, and blanching or mottling of the skin downstream from the injection site. Recognizing these signs early is critical because treatment options, while limited, are most effective when started quickly.⁴ Many medications have been injected into arteries without major consequences, but a number of drugs are consistently associated with severe harm including amputation, which makes early recognition vital.⁵

When the Drug Itself Enters the Bloodstream

Some medications are designed to be absorbed slowly through muscle or fat tissue. When those drugs accidentally enter a blood vessel, they flood the bloodstream at much higher concentrations than intended, sometimes producing toxic effects within seconds. This is most dramatically illustrated by local anesthetics, the numbing agents used in nerve blocks and dental procedures.

The risk of accidental intravascular injection during nerve-block procedures is well recognized, and the severity of resulting toxicity depends on the drug’s potency, the dose, and how fast it enters the circulation.⁶ In one reported case, a patient receiving ropivacaine for a brachial plexus nerve block developed grand mal seizures because the drug was inadvertently injected into a vein, producing peak plasma levels far above what a slow tissue injection would have caused.⁷ Fortunately, that patient experienced no heart problems, but that is not always the case.

Local anesthetic systemic toxicity, known by its acronym LAST, can progress from tingling around the mouth and ringing in the ears to seizures, and in the worst cases, to cardiac arrest. A case report of two infants who accidentally received an intravenous infusion of levobupivacaine, a drug intended for a regional nerve block, illustrates how quickly things can go wrong: the infants developed cardiovascular collapse and cardiac arrest, requiring full resuscitation efforts for twelve minutes before circulation was restored.⁸ Such events are rare, but they underscore why injecting near blood vessels demands careful technique.

Lipid Emulsion Rescue

One of the most significant advances in managing intravascular injection accidents has been the development of lipid emulsion therapy. When a fat-soluble local anesthetic reaches the heart and causes it to stop beating, infusing a solution of lipid (essentially a sterile fat emulsion, similar to what is used in intravenous nutrition) can pull the drug out of heart tissue and restore cardiac function. Over the past decade or so, this treatment has been adopted into emergency protocols by anesthesia organizations worldwide.⁹

A systematic review of lipid emulsion use in children who experienced LAST found it effective for both seizure-related and cardiac-related toxicity, and concluded it could be a lifesaving intervention for pediatric patients.¹⁰ The availability of this treatment has changed the risk calculus for regional anesthesia procedures, but it only works if the clinical team has the emulsion on hand and recognizes what is happening in time.

Nicolau Syndrome and Skin Necrosis

One of the more alarming-looking complications of hitting a blood vessel during an intramuscular injection is Nicolau syndrome, a rare condition in which the skin and underlying tissue at the injection site die off. It typically starts with severe pain immediately after the injection, followed by a purplish discoloration of the skin that can spread well beyond the injection point. In published cases, one patient who received a standard intramuscular injection of the painkiller diclofenac developed necrosis at the injection site on the hip, while another patient who received an antihistamine injection developed discoloration not just at the buttock injection site but also on the shoulder blade and elbow on the same side of the body.¹¹

The exact mechanism is debated, but Nicolau syndrome is thought to involve either direct injection into or around a small artery, causing spasm and blockage, or an inflammatory reaction that damages local vessels. What makes it distinctive is the widespread tissue death that can follow a seemingly routine injection. It has been reported with a variety of common drugs, not just ones you would expect to be irritating. Treatment usually involves supportive care and, in severe cases, surgical removal of the dead tissue.

Cosmetic Fillers and Vascular Blockage

The consequences of hitting a blood vessel take on a different character in cosmetic medicine. When dermal fillers, the gel-like substances injected to plump lips or smooth wrinkles, accidentally enter or compress a blood vessel, the filler can block blood flow to skin and deeper tissues. This can cause tissue death in the face, and in the most serious cases, blindness if the filler migrates into the blood supply of the retina. Vascular complications from fillers work through two mechanisms: the filler can physically compress a nearby vessel from outside, or it can enter the vessel and act as an internal blockage.¹²

These risks have driven a growing interest in using blunt-tipped cannulas instead of sharp needles for filler injections. Because a cannula tip is rounded, it tends to push blood vessels aside rather than piercing them. Some practitioners have also begun using ultrasound guidance during filler procedures to visualize vessels before injecting, an approach that allows precise placement while minimizing the chance of hitting a critical structure.¹³ The facial vasculature is complex and varies between individuals, which is part of why vascular complications with fillers, while uncommon, continue to occur even in experienced hands.

Oil-Based Injections and the Lungs

Certain injectable medications use an oil-based carrier to create a slow-release depot in muscle tissue. Testosterone undecanoate, used in hormone therapy, is a common example. If the needle happens to enter a vein during this type of injection, the oil can travel through the venous system to the lungs, where it causes a reaction known as pulmonary oil microembolism. Symptoms typically include a sudden coughing fit, shortness of breath, chest tightness, and sometimes dizziness or fainting, usually starting within minutes of the injection.¹⁴

Most episodes resolve on their own within thirty minutes or so as the body breaks down the tiny oil droplets in the lung capillaries. But the experience can be frightening, and it is the reason many providers require patients to sit in the clinic for a monitoring period after receiving oil-based intramuscular injections. The episode is not an allergic reaction to the medication itself; it is a mechanical consequence of oil entering the venous circulation.

Nerve Damage From Bleeding Around Vessels

Nerves and blood vessels often travel together in bundles, so puncturing a vessel during an injection can sometimes injure a nearby nerve as well. The damage does not always come from the needle itself. In some cases, it comes from the hematoma that forms afterward. Blood pooling inside a tight tissue compartment, particularly in the upper arm, can compress the nerve enough to disrupt its ability to conduct signals. In the brachial plexus region of the upper arm, the surrounding fascia creates a closed space where even a slow bleed can build up dangerous pressure. Distal circulation and pulses may remain normal even while the nerve is being silently compressed, which means the damage can go unrecognized until the patient notices weakness or numbness hours later.¹⁵

If compression is relieved quickly, the nerve’s protective sheath may recover fully. But if the pressure persists, the nerve fibers themselves can degenerate, leading to long-term weakness or chronic pain. This is one reason why persistent or worsening numbness after any injection near a major nerve should prompt medical evaluation rather than a wait-and-see approach.

Which Injection Sites Carry More Vascular Risk

Not all injection sites are created equal when it comes to the chance of hitting a blood vessel. An ultrasound study of common intramuscular injection sites in young adults found significant differences. In the thigh, major blood vessels running between the muscle layers were detected in the majority of subjects at one commonly used injection point, while an alternative spot on the outer thigh showed no major vessels at all. At the deltoid (upper arm), blood vessels were found in some subjects close to one landmark but absent at a slightly different position. The ventrogluteal site (upper outer hip) had vessels in a small number of subjects at certain locations.¹⁶

These findings highlight something practitioners have long understood intuitively: small shifts in needle placement can mean the difference between a clean intramuscular injection and a vessel puncture. The traditional teaching of using anatomical landmarks works well most of the time, but individual anatomy varies. A blood vessel may sit in an unexpected spot in one person that is safely distant in the next. This variability is part of why accidental vessel punctures cannot be completely eliminated, only minimized.

The Aspiration Debate

For decades, healthcare workers were taught to pull back on the syringe plunger briefly after inserting the needle and before injecting, a technique called aspiration. The idea is that if the needle tip sits inside a blood vessel, you will see blood flash into the syringe and know to reposition. In practice, though, the evidence supporting this ritual is thin. A systematic review of the literature on aspiration during intramuscular injections found that the decision to aspirate is driven more by what providers were taught during training and by a general fear of intravascular injection than by strong evidence that it reliably prevents complications.¹⁷

Many major health organizations, including the World Health Organization and the U.S. Centers for Disease Control and Prevention, no longer recommend routine aspiration for most vaccine injections. The reasoning is that the recommended injection sites for vaccines, such as the deltoid and the anterolateral thigh, do not have large blood vessels that a standard-length needle would reach. Aspiration also prolongs the injection and increases pain, which is a meaningful drawback for pediatric vaccinations. The practice is still considered appropriate in certain clinical contexts, such as when injecting near the dorsogluteal site or when administering medications where intravascular delivery would be particularly dangerous.

Blood Thinners and Injection Risk

People taking anticoagulants or antiplatelet drugs are often told to be cautious about intramuscular injections, and some providers avoid giving them altogether in these patients out of concern for uncontrolled bleeding. The actual evidence, however, suggests this fear is somewhat overblown. The large retrospective study mentioned earlier found that bleeding complications from intramuscular injections among anticoagulated hospitalized patients were rare, and their risk was probably not higher compared to patients who were not on blood thinners.¹ A separate study looking specifically at patients with rheumatic heart disease who needed regular intramuscular penicillin injections found no significant bleeding complications even when those patients were also receiving anticoagulant therapy.¹⁸

This does not mean blood thinners are irrelevant. A patient on anticoagulants who does develop a hematoma from a vessel puncture may bleed more and bruise more extensively than someone with normal clotting. The point is that the baseline risk of a serious bleed from a routine intramuscular injection is low enough that withholding a necessary injection solely because of anticoagulation is often not justified, especially when no practical alternative route exists.

Vasovagal Reactions and the Fear Factor

Sometimes what looks like a reaction to hitting a blood vessel is actually the body’s stress response to the injection itself. Vasovagal syncope, the classic fainting spell triggered by pain, anxiety, or the sight of blood, can produce dramatic symptoms: sudden dizziness, a drop in heart rate, pale skin, nausea, and loss of consciousness. In the overwhelming majority of cases this is a self-limited event that resolves in minutes with no lasting harm.

In rare instances, the vasovagal response can be extreme. One case report described a healthy 36-year-old woman who received a small trigger-point injection of lidocaine and almost immediately became dizzy, then unresponsive and pulseless, requiring CPR before she regained consciousness.¹⁹ The cause was not intravascular injection of the drug; it was a profound vasovagal event. Distinguishing between a vasovagal reaction and true systemic drug toxicity matters because the treatments are different, and misidentification in either direction can lead to the wrong response. Vasovagal episodes are far more common than true intravascular injection accidents, so when someone feels faint immediately after a shot, the likeliest explanation is their nervous system overreacting to the stimulus rather than the drug reaching their bloodstream.

Self-Injection and Harm Reduction

Outside clinical settings, people who self-inject medications such as insulin, testosterone, or growth hormone face many of the same risks on a smaller scale. A small bruise at an injection site is common and not a reason to panic. Bright red blood that spurts or pulses, severe pain radiating away from the injection site, or rapid swelling are signs that something more significant may have happened and warrant medical attention.

For people who inject illicit drugs, hitting a blood vessel carries additional layers of risk. The substances being injected are often mixed with fillers or contaminants that can cause severe local damage if they enter an artery. Repeated injections at the same site can damage vessel walls and surrounding tissue, making future injections riskier. Harm reduction guidance generally advises rotating injection sites, using the smallest practical needle gauge, injecting slowly, and stopping immediately if there is sharp pain or unusual resistance. None of these measures eliminates risk entirely, but they reduce the chance of the more serious complications described above.

Applying firm pressure to the injection site for several minutes afterward helps close any vessel that was nicked, reducing both bruising and the chance of a hematoma forming in deeper tissue. Ice can help limit swelling. Persistent pain, numbness, expanding bruising, or skin color changes that do not resolve within a few hours are all signals to seek medical evaluation rather than assume the problem will sort itself out.